Clinical Trials

Showing trials with last updates posted in 2026.

NCT07535827 | COMPLETED | EARLY_PHASE1
50 participants

Insulin Intratympanic Application

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-03-20
Completion:
2026-05-15
Conditions
  • Tympanic Membrane Perforation
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT07516366 | RECRUITING | PHASE2
16 participants

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2027-05-17
Completion:
2028-12-31
Conditions
  • Clear Cell Renal Cell Carcinoma
  • Stage II Renal Cell Cancer AJCC v8
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
NCT07512596 | RECRUITING | PHASE2
48 participants

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-07-21
Completion:
2027-07-31
Conditions
  • Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Interventions
  • DRUG
No Results Yet
NCT07468071 | RECRUITING | PHASE1/PHASE2
40 participants

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-06-08
Completion:
2029-06-11
Conditions
  • Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer
  • Advanced Solid Tumors Harboring the KRAS G12C Mutation
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page